FDC Limited (NSE:FDC)

Theseus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	527.72	254.2	238.86	377.25	304.32
Short-Term Investments	4,847	615.53	-	-	-
Trading Asset Securities	-	3,885	4,573	5,008	5,248
Cash & Short-Term Investments	5,374	4,754	4,812	5,385	5,553
Cash Growth	13.04%	-1.19%	-10.64%	-3.02%	4.35%
Accounts Receivable	1,088	1,174	1,226	821.74	1,105
Other Receivables	-	67.48	10.6	22.38	62.52
Receivables	1,103	1,252	1,244	849.67	1,171
Inventory	3,750	3,889	3,285	3,047	2,149
Prepaid Expenses	-	124.43	88.84	85.29	77.11
Other Current Assets	659.72	644.88	839.5	634.98	387.3
Total Current Assets	10,887	10,665	10,269	10,002	9,337
Property, Plant & Equipment	9,841	9,376	8,918	8,052	7,040
Long-Term Investments	5,432	3,928	3,485	3,847	2,654
Other Intangible Assets	42.53	41.82	55.36	46.33	43.95
Other Long-Term Assets	927.15	662.63	695.91	749.34	484.47
Total Assets	27,138	24,681	23,429	22,702	19,562
Accounts Payable	2,052	1,860	1,785	1,369	772.76
Accrued Expenses	-	654.13	622.94	748.16	657.99
Short-Term Debt	-	0.32	0.76	-	-
Current Portion of Long-Term Debt	-	-	-	1	1.36
Current Portion of Leases	90.52	79.11	74.41	68.23	70.03
Current Income Taxes Payable	78.4	38.39	128.39	130.77	130.54
Other Current Liabilities	1,396	473.93	504.16	404	402.19
Total Current Liabilities	3,616	3,106	3,116	2,722	2,035
Long-Term Debt	1.1	2.47	5.63	6.52	7.22
Long-Term Leases	120.07	123.29	202.4	246.3	67.96
Long-Term Deferred Tax Liabilities	229.01	172.32	110.85	160.8	108.77
Other Long-Term Liabilities	360.67	304.9	180.9	3.26	3.92
Total Liabilities	4,327	3,709	3,615	3,138	2,223
Common Stock	162.81	165.91	168.81	168.81	168.81
Retained Earnings	-	20,671	19,539	19,290	17,115
Treasury Stock	-	-3.1	-2.9	-	-
Comprehensive Income & Other	22,648	137.39	115.15	109.11	57.88
Total Common Equity	22,811	20,972	19,820	19,568	17,341
Minority Interest	-	-	-6.44	-4.29	-1.73
Shareholders' Equity	22,811	20,972	19,814	19,564	17,340
Total Liabilities & Equity	27,138	24,681	23,429	22,702	19,562
Total Debt	211.68	205.19	283.2	322.04	146.56
Net Cash (Debt)	5,163	4,549	4,529	5,063	5,406
Net Cash Growth	13.48%	0.46%	-10.55%	-6.35%	4.56%
Net Cash Per Share	31.72	27.70	27.24	29.99	31.80
Filing Date Shares Outstanding	162.48	162.81	165.91	168.81	168.81
Total Common Shares Outstanding	162.48	162.81	165.91	168.81	168.81
Working Capital	7,271	7,559	7,153	7,280	7,303
Book Value Per Share	140.39	128.81	119.47	115.92	102.73
Tangible Book Value	22,768	20,930	19,765	19,522	17,297
Tangible Book Value Per Share	140.13	128.55	119.13	115.64	102.47
Land	-	4,101	4,101	4,101	4,101
Buildings	-	1,451	1,674	1,726	1,723
Machinery	-	3,506	3,169	2,948	2,695
Construction In Progress	-	2,609	1,977	1,047	192.11
Leasehold Improvements	-	38.4	38.4	38.4	38.4

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.